No one should take a peptide in the dark.
A neutral, independent platform that shows people how what they take is really affecting their body, using the same kind of tools as a clinical study.
Built by the people who work with health data every day.
Peptide BioCare was developed by medical researchers, healthcare data specialists and doctors from BioHealthcare Group. We have spent years building diagnostic testing, remote monitoring and clinical research systems. We saw a gap that no one was filling, and people were getting hurt in it.
So we built something different: a neutral and independent place where anyone can see, in clear data, how their peptide or medication is working, using clinical research style tools such as baseline testing, continuous monitoring and structured follow-up.
We do not sell opinions. We are not a regulator. We do not judge. We measure, we show you the truth about your own body, and we help you stay safe.
It starts with hope. Sometimes it ends in an ambulance.
You find it online at two in the morning. The before and after photos look incredible. The vial arrives in a plain envelope, with a label you cannot read and no leaflet inside.
You draw it up anyway. Because you want to feel better. Because everyone else seems to be doing it. Because you are tired of waiting.
And then you wait to see what happens, completely alone, with no one watching.
Behind every one of these outcomes is a person who only wanted to look and feel better.
Illegal, fake and unfinished drugs are now sold everywhere.
Demand for peptides has exploded faster than the systems built to keep people safe. Three kinds of product now reach people every day.
Copies of real medicines, made in illegal workshops, that may contain the wrong drug, the wrong dose or nothing at all.
Peptides that are not approved anywhere, sold as "research use only" through websites, gyms and social media.
Drugs still in clinical trials, already being sold to the public before the evidence is complete.
Medical products in low and middle income countries are estimated to be substandard or falsified, and they can cause serious illness or even death.
World Health OrganizationWHO has recorded rising reports of falsified semaglutide in every region of the world since 2022.
World Health Organization, 2024Shipments of unapproved weight loss peptides seized at a single US port, including drugs still in clinical trials.
US Customs and Border Protection, 2026What this will mean for healthcare
- More emergency admissions from reactions, infections and dangerously low blood sugar.
- Damage that is found late, after months of silent strain on the liver, kidneys and heart.
- Doctors treating patients without knowing what they took, how much, or where it came from.
- Pressure on health systems that are already stretched, and lost trust in genuine medicines.
Because wanting to feel good is human.
Nobody takes an unlicensed peptide because they want to get hurt. They take it because they want to look better in the mirror, lose the weight that has followed them for years, recover from an injury faster, sleep through the night, feel younger, or simply feel confident again.
Social media shows the transformations, never the side effects. Friends share what worked for them. And approved medicines can be hard to get: waiting lists, strict criteria, and branded weight loss treatments that can cost hundreds of dollars a month without insurance.
We understand all of it. That is exactly why we do not judge. We would rather you were safe than lectured.
Safe medicines take years. People do not want to wait.
Bringing a new medicine from discovery to approval is one of the slowest and most expensive journeys in science. That is how it should be. But it leaves a long gap that the illegal market is happy to fill.
On average from discovery to approval.
Average cost per new medicine, including the many that fail.
Medicines that enter clinical trials never reach approval.
Source: Biotechnology Innovation Organization. During those years, copies and unfinished versions of promising drugs are already being sold online.
So we built the service that was missing.
We stand in the middle, neutral and independent, helping everybody: the people taking peptides, the doctors treating them, and a healthcare system that needs better information.
We are not a regulator or licensing authority, and we do not give medical opinions. We never share your data with drug companies, authorities or doctors. We measure, we check and we give the data to you.
